<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Kolestatik karaciğer hasarı &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/kolestatik-karaciger-hasari/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 10 Jan 2026 08:54:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Kolestatik karaciğer hasarı &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>FDX1-Driven Cuproptosis Worsens Cholestatic Liver Damage</title>
		<link>https://bioengineer.org/fdx1-driven-cuproptosis-worsens-cholestatic-liver-damage/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 10 Jan 2026 08:54:24 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bakır birikimi]]></category>
		<category><![CDATA[Bakırla tetiklenen hücre ölümü]]></category>
		<category><![CDATA[FDX1]]></category>
		<category><![CDATA[Kolestatik karaciğer hasarı]]></category>
		<category><![CDATA[Taurokolit asit]]></category>
		<guid isPermaLink="false">https://bioengineer.org/fdx1-driven-cuproptosis-worsens-cholestatic-liver-damage/</guid>

					<description><![CDATA[In a groundbreaking revelation slated to redefine our understanding of liver diseases, cutting-edge research has illuminated the pivotal role of FDX1-mediated cuproptosis in driving cholestatic liver injury. This newly uncovered mechanism, exacerbated by taurocholic acid’s enhancement of copper accumulation, offers fresh insights into the molecular interplay underlying liver pathologies, potentially steering the future of therapeutic [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315612</post-id>	</item>
	</channel>
</rss>
